Spun out of Tübingen, Justus Liebig University Gießen and Münster, Atriva Therapeutics has raised an initial $1.4m to progress next-generation antiviral drugs for conditions including influenza.

SoftBank has dropped plans to buy a majority stake in WeWork, instead supplying $2bn of equity funding at a $47bn valuation.

Months after raising $500m in an FAW and Contemporary Amperex-backed series B round, the electric car developer is seeking another $500m before it floats.

Schrödinger raised $85m from investors including WuXi AppTec and GV and will use the money to expand the capabilities of its drug discovery software.

Ping An, Samsung, CLP, Tasly and Health 100 have all taken part in a series C round for the diabetes management technology provider.

Biontech has received $91.5m in equity funding as part of the extension of a deal to develop a cancer immunotherapy candidate with Sanofi.

The online pharmaceutical distributor has secured $73m in a series C-plus round that follows a Tencent-led round last April.

The genomic testing platform developer has now raised some $140m, eight years after being co-founded in EPFL's Innovation Park by researchers from EMBL, Stanford and Geneva University.

Generation Investment Management has led the Swisscom-backed genomic testing platform developer's latest round, boosting its overall funding to $140m.

Celgene and Evotec have put capital into Exscientia as the Dundee-founded automated drug discovery services provider added Roche to its roster of development partners.